50 results
S-8
EX-99.1
SYRE
Spyre Therapeutics Inc.
22 Dec 23
Registration of securities for employees
5:00pm
) adjust performance goals or Performance Factors as the Committee deems necessary or appropriate;
(o) adopt rules and/or procedures (including … overlap and Participants may participate simultaneously with respect to Options that are subject to different performance goals and other criteria
PRE 14A
SYRE
Spyre Therapeutics Inc.
7 Apr 23
Preliminary proxy
4:02pm
and procedures are effective in implementing our compensation philosophy and in achieving our goals. Accordingly, we ask our stockholders to vote … that providing an equity stake in the future success of our business encourages our employees to be highly motivated to achieve our long-term business goals
8-K
EX-99.1
gucclqrl
24 Oct 23
Regulation FD Disclosure
9:00am
8-K
EX-99.1
hiap296vns6tq
8 Sep 23
Material Modifications to Rights of Security Holders
5:05pm
S-8
EX-99.2
43aswnr7b3rg koesqx
22 Dec 23
Registration of securities for employees
5:00pm
8-K
EX-99.1
sl7wq06ehd3ha1okcgg0
23 Jun 23
Entry into a Material Definitive Agreement
9:16am
PRER14A
ssreb3 zbt2tyyti
6 Oct 23
Preliminary revised proxy
9:40pm
8-K
EX-10.1
cy01b1jr58y2kgn1
23 Jul 18
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.2
1ud3m 7lvb
6 Dec 21
Aeglea BioTherapeutics Announces Achievement of Primary Endpoint in Phase 3 Study of Pegzilarginase in Patients with Arginase 1 Deficiency
6:30am
8-K
EX-99.2
w6vkdy6
4 Aug 22
Aeglea BioTherapeutics Reports Second Quarter 2022 Financial Results and Provides Program Updates
6:01am
8-K
EX-99.1
zgs1x26 xf
5 Jan 22
Regulation FD Disclosure
7:01am